Novo CEO pressed by Senate to cut price ranges of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers about the checklist charges of Wegovy and copyright whenever they pledge to help keep the medicines on their formularies. Hear the https://dallastafpu.blazingblog.com/30705135/everything-about-healthcare-news